Daehan New Pharm Co., Ltd. (KOSDAQ:054670)

Daehan New Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Mar 27, 2025	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Market Capitalization	94,177	69,213	85,861	112,471	123,807	59,360
Market Cap Growth	12.90%	-19.39%	-23.66%	-9.16%	108.57%	-63.45%
Enterprise Value	148,393	113,126	127,357	145,501	147,521	89,584
Last Close Price	6710.00	5039.86	6252.10	8189.77	8800.66	4395.56
PE Ratio	-	-	133.42	-	343.24	10.33
PS Ratio	1.73	1.44	1.93	2.27	3.06	1.75
PB Ratio	1.12	1.02	1.16	1.53	1.62	0.77
P/TBV Ratio	1.45	1.07	1.23	1.54	1.63	0.77
P/FCF Ratio	-	38.80	-	-	14.73
P/OCF Ratio	59.39	269.50	25.12	-	-	13.98
EV/Sales Ratio	2.72	2.36	2.86	2.93	3.65	2.64
EV/EBITDA Ratio	25.02	23.27	20.78	28.11	31.46	158.55
EV/EBIT Ratio	34.18	32.78	23.77	31.88	34.78	1490.40
EV/FCF Ratio	-	57.56	-	-	22.23
Debt / Equity Ratio	0.59	0.70	0.54	0.48	0.32	0.40
Debt / EBITDA Ratio	7.35	9.85	6.46	6.78	5.26	55.03
Debt / FCF Ratio	-	-	17.91	-	-	7.72
Asset Turnover	0.42	0.38	0.36	0.43	0.35	0.29
Inventory Turnover	3.34	3.88	3.55	3.86	2.78	2.54
Quick Ratio	0.97	1.03	1.09	1.10	1.46	0.81
Current Ratio	1.15	1.20	1.27	1.42	1.88	1.12
Return on Equity (ROE)	-5.45%	-7.79%	0.87%	-3.70%	2.11%	7.94%
Return on Assets (ROA)	2.09%	1.70%	2.73%	2.47%	2.30%	0.03%
Return on Capital (ROIC)	2.30%	1.88%	3.02%	2.72%	2.54%	0.03%
Return on Capital Employed (ROCE)	5.40%	4.30%	6.50%	5.60%	4.90%	0.10%
Earnings Yield	-4.25%	-7.99%	0.75%	-2.46%	0.29%	9.68%
FCF Yield	-0.81%	-1.42%	2.58%	-10.04%	-3.47%	6.79%
Dividend Yield	1.49%	-	-	-	-	-
Buyback Yield / Dilution	-6.45%	0.24%	2.36%	0.07%	-3.67%	-20.86%
Total Shareholder Return	-4.96%	0.24%	2.36%	0.07%	-3.67%	-20.86%

Updated Nov 13, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.